AbCellera grew out of the idea that single-cell microfluidics and next-generation technologies can radically change how we discover drugs. But this isn’t just about having advanced technology. It comes from building a world-class group of innovators.
Our multidisciplinary team of cell biologists, biochemists, engineers, data scientists, machine learning experts, and business professionals is working on some of the toughest areas of disease. We push the limits of antibody discovery to help partners tackle the world’s most urgent medical challenges.
Our impact is measured by the success of our partners and the advancement of antibody therapies. We are motivated by the feeling that our days are being well spent. That our work really matters.